Home

News

Congratulations to our Door Tenant Eleonora Rosati on her promotion.31 March 2017 8 New Square congratulate Eleonora Rosati on her promotion to Associate Professor in Intellectual Property Law at the University of Southampton.
Fujifilm v Abbvie [2017] EWHC 395 (Pat)28 March 2017Michael Tappin QC, Andrew Lykiardopoulos QC and Mark Chacksfield appeared for the Defendant (“AbbVie”) in this action concerning certain of AbbVie’s patents and applications for the anti-inflammatory drug adalimumab (marketed by AbbVie as “Humira”). The Claimants (“FKB” and “SB/Biogen”) sought declarations (the “Declarations”) to the effect that use of their biosimilar adalimumab products in certain […]
Charlotte May gives keynote address at the SPC Workshop in Munich23 March 2017Charlotte May QC was invited to give the keynote address at the SPC Workshop in Munich, organised by the Max Planck Institute in collaboration with the German Patent Office. The Workshop was attended by lawyers, patent attorneys, industry specialists and national patent office representatives from across Europe and involved a stimulating debate about all aspects […]
Teva UK Ltd v Merck Sharp & Dohme Corp [2017] EWHC 539 (Pat)21 March 2017Charlotte May QC and Lindsay Lane represented the first claimant (“Teva”) in its successful challenge of the defendant’s (“Merck”) supplementary protection certificate (SPC) for an anti-viral drug marketed as Atripla. The SPC covered a combination of the active ingredient efavirenz together with emtricitabine and tenofovir. The Court agreed with Teva’s case that the SPC failed […]
Synthon B.V. v Teva Pharmaceutical Industries Limited [2017] EWCA Civ 14821 March 2017Andrew Lykiardopoulos QC represented the Appellant, “Synthon” in its appeal concerning Teva’s patent for glatiramer acetate (marketed as “Copaxone”). The Patent related to a method of making glatiramer acetate with limited levels bromine and free metal impurities. Synthon had challenged the validity of the patent on grounds of lack of novelty, obviousness and insufficiency. At […]
Charlotte May gives keynote address at the SPC Workshop in Munich20 March 2017Charlotte May QC was invited to give the keynote address at the SPC Workshop in Munich, organised by the Max Planck Institute in collaboration with the German Patent Office. The Workshop was attended by lawyers, patent attorneys, industry specialists and national patent office representatives from across Europe and involved a stimulating debate about all aspects […]
8 New Square awarded UK IP Set of the year at the MIP awards dinner10 March 2017For the second year running, 8 New Square were awarded the UK IP Set of the year by the Managing Intellectual Property Global publication at an awards dinner in the Savoy Hotel in London on 9th March. James Abrahams QC accompanied by Martin Williams collected the award.
8 New Square awarded UK IP Set of the year at the MIP awards dinner10 March 2017 For the second year running, 8 New Square were awarded the UK IP Set of the year by the Managing Intellectual Property Global publication at an awards dinner in the Savoy Hotel in London on 9th March. James Abrahams QC accompanied by Martin Williams collected the award.
Fujifilm Kyowa Kirin Biologics Company v Abbvie Biotechnology and Others3 March 2017Michael Tappin QC, Andrew Lykiardopoulos QC and Mark Chacksfield appeared for the Defendant (“AbbVie”) in this action concerning certain of AbbVie’s patents and applications for the anti-inflammatory drug adalimumab (marketed by AbbVie as “Humira”). The Claimants (“FKB” and “SB/Biogen”) sought declarations (the “Declarations”) to the effect that use of their biosimilar adalimumab products in certain […]
Argos Ltd v Argos Systems Inc [2017] EWHC 231 (Ch)15 February 2017Three members of chambers acted in a substantial trade mark infringement and passing off dispute between the British retailer, Argos Ltd (‘Argos UK’), and an American software company, Argos Systems Inc. The claim concerned the defendant’s use of the sign ARGOS in its domain name www.argos.com and on its website, on which it had placed […]